Epigenetic modulation of Cdk5 contributes to memory deficiency induced by amyloid fibrils

Experimental Brain Research

Volumn 233, Issue 1, 2015, Pages 165-173

  Li, Liuhong ^a   Zhang, Chunqiang ^b   Zi, Xiaohong ^a   Tu, Qiuyun ^a   Guo, Ke ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b China   (China)

Author keywords

Amyloid fibrils; Cyclin dependent kinase 5; Epigenetic; Memory deficiency; Synaptic plasticity; Tau

Indexed keywords

AMYLOID; BISULFITE; CYCLIN DEPENDENT KINASE 5; CYTOSINE; HISTONE H3; MESSENGER RNA; ROSCOVITINE; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; HIPPOCAMPAL CA1 REGION; HISTONE ACETYLATION; LATENT PERIOD; MALE; METHYLATION; MORRIS WATER MAZE TEST; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; HIPPOCAMPUS; MAZE TEST; MEMORY DISORDER; METABOLISM; NERVE CELL; PHYSIOLOGY; RECOGNITION; WISTAR RAT;

AMYLOID; ANIMALS; CYCLIN-DEPENDENT KINASE 5; EPIGENESIS, GENETIC; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; NEURONS; PROMOTER REGIONS, GENETIC; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY);

EID: 84922005355     PISSN: 00144819     EISSN: 14321106     Source Type: Journal    
DOI: 10.1007/s00221-014-4100-0     Document Type: Article

References (33)

1. Adwan L, Zawia NH (2013) Epigenetics: a novel therapeutic approach for the treatment of Alzheimer’s disease. Pharmacol Ther 139:41–50. doi:10.1016/j.pharmthera.2013.03.010
2. Ahmed T, Enam SA, Gilani AH (2010) Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer’s disease. Neuroscience 169:1296–1306. doi:10.1016/j.neuroscience.2010.05.078
3. Chacon MA, Barria MI, Soto C, Inestrosa NC (2004) Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits. Mol Psychiatry 9:953–961. doi:10.1038/sj.mp.4001516
4. Cheung ZH, Ip NY (2012) Cdk5: a multifaceted kinase in neurodegenerative diseases. Trends Cell Biol 22:169–175. doi:10.1016/j.tcb.2011.11.003
5. Cheung ZH, Fu AK, Ip NY (2006) Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 50:13–18. doi:10.1016/j.neuron.2006.02.024
6. Colledge M et al (2003) Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 40:595–607
7. Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M (2014) Global changes in DNA methylation and hydroxymethylation in Alzheimer’s disease human brain. Neurobiol Aging 35:1334–1344. doi:10.1016/j.neurobiolaging.2013.11.031
8. Cruz JC, Tsai LH (2004) Cdk5 deregulation in the pathogenesis of Alzheimer’s disease. Trends Mol Med 10:452–458. doi:10.1016/j.molmed.2004.07.001
9. Feng J et al (2010) Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13:423–430. doi:10.1038/nn.2514
10. Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG (2000) Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. J Neurosci Res 62:463–472. doi:10.1002/1097-4547(20001101)62:3<463:AID-JNR16>3.0.CO;2-7
11. Graff J, Kim D, Dobbin MM, Tsai LH (2011) Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol Rev 91:603–649. doi:10.1152/physrev.00012.2010
12. Graff J et al (2012) An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483:222–226. doi:10.1038/nature10849
13. Guan JS et al (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55–60. doi:10.1038/nature07925
14. Lai KO et al (2012) TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory. Nat Neurosci 15:1506–1515. doi:10.1038/nn.3237
15. Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN (1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34:21–29
16. Lee J, Yun N, Kim C, Song MY, Park KS, Oh YJ (2014) Acetylation of cyclin-dependent kinase 5 is mediated by GCN5. Biochem Biophys Res Commun 447:121–127. doi:10.1016/j.bbrc.2014.03.118
17. Lian S et al (2013) Transcriptional activation of mina by sp1/3 factors. PLoS one 8:e80638. doi:10.1371/journal.pone.0080638
18. Lubin FD, Roth TL, Sweatt JD (2008) Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 28:10576–10586. doi:10.1523/JNEUROSCI.1786-08.2008
19. Mapelli M, Massimiliano L, Crovace C, Seeliger MA, Tsai LH, Meijer L, Musacchio A (2005) Mechanism of CDK5/p25 binding by CDK inhibitors. J Med Chem 48:671–679. doi:10.1021/jm049323m
20. Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD (2009) Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer’s disease. PloS one 4:e6617. doi:10.1371/journal.pone.0006617
21. Pascual M, Do Couto BR, Alfonso-Loeches S, Aguilar MA, Rodriguez-Arias M, Guerri C (2012) Changes in histone acetylation in the prefrontal cortex of ethanol-exposed adolescent rats are associated with ethanol-induced place conditioning. Neuropharmacology 62:2309–2319. doi:10.1016/j.neuropharm.2012.01.011
22. Pita-Almenar JD, Zou S, Colbert CM, Eskin A (2012) Relationship between increase in astrocytic GLT-1 glutamate transport and late-LTP. Learn Mem 19:615–626. doi:10.1101/lm.023259.111
23. Provencal N et al (2013) Differential DNA methylation regions in cytokine and transcription factor genomic loci associate with childhood physical aggression. PLoS one 8:e71691. doi:10.1371/journal.pone.0071691
24. Roselli F, Livrea P, Almeida OF (2011) CDK5 is essential for soluble amyloid beta-induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton. PLoS one 6:e23097. doi:10.1371/journal.pone.0023097
25. Rudenko A, Tsai LH (2014) Epigenetic modifications in the nervous system and their impact upon cognitive impairments. Neuropharmacology 80:70–82. doi:10.1016/j.neuropharm.2014.01.043
26. Sabatino L et al (2012) UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression. Oncogene 31:5061–5072. doi:10.1038/onc.2012.3
27. Shipton OA et al (2011) Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J Neurosci 31:1688–1692. doi:10.1523/JNEUROSCI.2610-10.2011
28. Smith GK, Kesner RP, Korenberg JR (2013) Dentate gyrus mediates cognitive function in the Ts65Dn/DnJ mouse model of down syndrome. Hippocampus. doi:10.1002/hipo.22229
29. Sobue K, Agarwal-Mawal A, Li W, Sun W, Miura Y, Paudel HK (2000) Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. J Biol Chem 275:16673–16680. doi:10.1074/jbc.M000784200
30. Sung YM et al (2013) Mercaptoacetamide-based class II HDAC inhibitor lowers Abeta levels and improves learning and memory in a mouse model of Alzheimer’s disease. Exp Neurol 239:192–201. doi:10.1016/j.expneurol.2012.10.005
31. Typlt M, Mirkowski M, Azzopardi E, Ruettiger L, Ruth P, Schmid S (2013) Mice with Deficient BK Channel Function Show Impaired Prepulse Inhibition and Spatial Learning, but Normal Working and Spatial Reference Memory. PLoS one 8:e81270. doi:10.1371/journal.pone.0081270
32. van den Hove DL, Kenis G, Rutten BP (2014) Epigenetic dysregulation in Alzheimer’s disease: cause or consequence? Epigenomics 6:9–11. doi:10.2217/epi.13.84
33. Zempel H, Thies E, Mandelkow E, Mandelkow EM (2010) Abeta oligomers cause localized Ca(2 +) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 30:11938–11950. doi:10.1523/JNEUROSCI.2357-10.2010